Mindset Pharma (MSET.C) announced their lead clinical candidate, MSP-1014. MSP-1014 is a differentiated psilocybin-based compound from Mindset’s Family 1 of novel, patent-pending psychedelic compounds. MSET plans on moving forward…
Latest News
Bitcoin bulls beware! Topping pattern to trigger more downside?
Top 5 Gainers and Losers: NUMI.TO, FOBI.V, IDK.CN
Top 5 Gainers and Losers: COR.V, PGDC.V, LOT.V
Atco Mining and Standard Uranium show promising early uranium drill results
Standard Uranium (STND.V) intersects anomalous radioactivity
Top 5 Gainers and Losers: SVA.TO, BRM.V, COR.V